SI1515729T1 - Kvaternizirane amonij ciklodekstrinske spojine - Google Patents

Kvaternizirane amonij ciklodekstrinske spojine

Info

Publication number
SI1515729T1
SI1515729T1 SI200331202T SI200331202T SI1515729T1 SI 1515729 T1 SI1515729 T1 SI 1515729T1 SI 200331202 T SI200331202 T SI 200331202T SI 200331202 T SI200331202 T SI 200331202T SI 1515729 T1 SI1515729 T1 SI 1515729T1
Authority
SI
Slovenia
Prior art keywords
compound
alkylene
group selected
cyclodextrin
cyclodextrin compounds
Prior art date
Application number
SI200331202T
Other languages
English (en)
Slovenian (sl)
Inventor
Georg Ludwig Kis
Christian Schoch
Jozsef Szejtli
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SI1515729T1 publication Critical patent/SI1515729T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SI200331202T 2002-06-13 2003-06-12 Kvaternizirane amonij ciklodekstrinske spojine SI1515729T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP02013074 2002-06-13
EP02028554 2002-12-20
EP03740232A EP1515729B1 (en) 2002-06-13 2003-06-12 Quaternised ammonium cyclodextrin compounds
PCT/EP2003/006192 WO2003105867A1 (en) 2002-06-13 2003-06-12 Quaternised ammonium cyclodextrin compounds

Publications (1)

Publication Number Publication Date
SI1515729T1 true SI1515729T1 (sl) 2008-08-31

Family

ID=29737927

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331202T SI1515729T1 (sl) 2002-06-13 2003-06-12 Kvaternizirane amonij ciklodekstrinske spojine

Country Status (15)

Country Link
US (4) US20050222085A1 (enExample)
EP (1) EP1515729B1 (enExample)
JP (2) JP4773721B2 (enExample)
CN (1) CN100589809C (enExample)
AT (1) ATE386532T1 (enExample)
AU (1) AU2003276957A1 (enExample)
BR (1) BR0311722A (enExample)
CA (1) CA2487332C (enExample)
CY (1) CY1108099T1 (enExample)
DE (1) DE60319221T2 (enExample)
DK (1) DK1515729T3 (enExample)
ES (1) ES2301807T3 (enExample)
PT (1) PT1515729E (enExample)
SI (1) SI1515729T1 (enExample)
WO (1) WO2003105867A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100678824B1 (ko) * 2005-02-04 2007-02-05 한미약품 주식회사 용해성이 증가된 무정형 타크로리무스 고체분산체 및 이를포함하는 약제학적 조성물
EP2522343A1 (en) 2006-03-28 2012-11-14 Javelin Pharmaceuticals, Inc. Formulations of Low Dose Diclofenac and Beta-Cyclodextrin
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
CN101757621B (zh) * 2008-11-28 2012-07-04 天津金耀集团有限公司 一种眼部抗炎的环糊精包合药物组合物
US9642920B2 (en) * 2009-06-03 2017-05-09 Case Western Reserve University Therapeutic agent delivery system and method
CN102276761A (zh) * 2010-06-11 2011-12-14 南京理工大学 单取代铵基正电型-β-环糊精及其制备方法
GB201114459D0 (en) * 2011-08-22 2011-10-05 Isis Innovation Anti-bacterial compounds
CN103497275B (zh) * 2013-08-09 2015-12-23 华北电力大学（保定） 一种抗菌、抗病毒胍盐星形聚合物及其制备方法和应用
CZ307458B6 (cs) * 2014-11-25 2018-09-12 Spur A.S. Vícevrstvý kryt rány s aktivní vrstvou a způsob jeho výroby
EP3227379B1 (en) * 2014-12-02 2020-07-29 B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University Quaternized starches for use as anti-microbial agents
CN109487588B (zh) * 2018-11-19 2021-04-20 绍兴永通印花有限公司 一种印花用涤纶织物处理液及其使用方法
CN113056516B (zh) 2019-02-14 2022-05-13 赛克洛珀股份有限公司 带有电荷的环糊精聚合物材料以及其制造和使用方法
CN109836512A (zh) * 2019-03-04 2019-06-04 西南石油大学 一种新型β-CD双子表面活性剂为稠化剂的清洁压裂液
CN112386710A (zh) * 2020-12-09 2021-02-23 星拜(苏州)生物科技有限公司 一种利用包埋技术改善紫檀芪水溶性的方法
CN116987213B (zh) * 2022-04-26 2025-09-09 中国石油化工股份有限公司 一种具有表面活性剂功能的化合物、一种表面活性剂及其制备方法
KR20250161522A (ko) 2023-01-12 2025-11-17 사이클로퓨어, 인코포레이티드 중합체 시클로덱스트린 흡착제의 재생

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453257A (en) * 1967-02-13 1969-07-01 Corn Products Co Cyclodextrin with cationic properties
JPS58210901A (ja) * 1982-06-01 1983-12-08 Kao Corp シクロデキストリン誘導体およびその製造方法
IT1229133B (it) * 1989-03-09 1991-07-22 Farmhispania Sali ammonici di policiclodestrine per l'impiego come agenti ipocolesterolemizzanti
KR927003645A (ko) * 1990-05-21 1992-12-18 후지다 히로미찌 씨클로덱스트린 유도체
JPH0481401A (ja) * 1990-07-24 1992-03-16 Toppan Printing Co Ltd シクロデキストリン誘導体
JPH0665307A (ja) * 1992-06-17 1994-03-08 Sankyo Co Ltd シクロデキストリン誘導体
AU3609795A (en) * 1994-10-10 1996-05-02 Novartis Ag Ophthalmic and aural compositions containing diclofenac potassium
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
WO1999042111A1 (en) * 1998-02-23 1999-08-26 Cyclops, Ehf. High-energy cyclodextrin complexes

Also Published As

Publication number Publication date
CA2487332C (en) 2012-05-15
WO2003105867A1 (en) 2003-12-24
JP4773721B2 (ja) 2011-09-14
CY1108099T1 (el) 2014-02-12
US20130137657A1 (en) 2013-05-30
AU2003276957A1 (en) 2003-12-31
JP2011006448A (ja) 2011-01-13
PT1515729E (pt) 2008-05-30
ATE386532T1 (de) 2008-03-15
EP1515729B1 (en) 2008-02-20
CA2487332A1 (en) 2003-12-24
EP1515729A1 (en) 2005-03-23
US20120004158A1 (en) 2012-01-05
CN100589809C (zh) 2010-02-17
BR0311722A (pt) 2005-03-01
CN1658888A (zh) 2005-08-24
DK1515729T3 (da) 2008-06-16
ES2301807T3 (es) 2008-07-01
US20090110734A1 (en) 2009-04-30
US20050222085A1 (en) 2005-10-06
DE60319221D1 (de) 2008-04-03
DE60319221T2 (de) 2009-03-05
JP2005529175A (ja) 2005-09-29

Similar Documents

Publication Publication Date Title
PT1515729E (pt) Compostos de ciclodextrina de amónio quaternário
Jeon et al. Effect of antimicrobial activity by chitosan oligosaccharide N-conjugated with asparagine
RU2225404C2 (ru) ПРОИЗВОДНЫЕ ПИПЕРАЗИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ ФАКТОРА Хa
WO2004014384A3 (en) Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors
EP1481965A4 (en) AROMATIC AMINO ACID DERIVATIVES AND MEDICAL COMPOSITIONS
HRP20060275A2 (en) 6-0-supstituted ketolides having antibacterial activity
CA2155673A1 (en) N-alkyl-2-substituted atp analogues
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
WO2011072853A3 (en) Conditioning composition for hair
WO2002004466A3 (en) Catalyst for asymmetric (transfer) hydrogenation
BR0315302A (pt) Benzoxazinonas substituìdas e seus usos
TR200702943A2 (tr) Uçuculuğu düşük olan klomazon terkipleri
DE602005009924D1 (en) Synthetische multiple quaternäre ammoniumsalze
MD1788G2 (ro) Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
DE60239000D1 (de) Carbazuckeraminderivate und mittel gegen störungenff enthalten
EP1027880A3 (de) Verwendung von quaternären Ammoniumverbindungen als Antitranspirantien
AR012883A1 (es) Compuestos derivados de ciclobutilamina sustituida, composicion farmaceutica y agente antibacteriano.
DE602005018100D1 (de) Zu lipidmembranen in archeabakterien analoge verbindungen und liposomale zusammensetzungen mit diesen verbindungen
HUP0204217A2 (en) Novel a-500359 derivatives
AU3300797A (en) Selenophene anti-tumor agents
NO975402L (no) Nye benzopyran forbindelser, fremgangsmÕte ved fremstilling av dem og farmas÷ytiske sammensetninger som inneholder dem
ES440147A1 (es) Un proceso para la preparacion de derivados de la nitrosou- rea.
PRUESS et al. ANTIMETABOLITES PRODUCED BY MICROORGANISMS. XI. 1) 1-(S)-HYDROXY-2-(S, S)-VALYLAMIDO-CYCLOBUTANE-1-ACETIC ACID
KR960010739A (ko) 암모늄염을 함유하는 예비 중합체 및 이의 제조방법
RU2220151C2 (ru) Стероидные производные, способы их получения, фармацевтическая композиция, способ лечения, способ подавления роста микробов